MCIDT affiliate Jason Pogue finds overlap in risk factors associated with carbapenem-resistant (CR) and extended-β-lactam resistant (EBR) Pseudomonas aeruginosa in hospitalized patients, something clinicians should consider when developing treatment plans
Key Terms: Antibiotic Resistance, Pseudomonas, Risk Factors
